Laurichesse H, Peigue-Lafeuille H, Gibert R, Fuchs F, Beytout J, Rey M
Infectious Diseases Ward, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.
J Travel Med. 1997 Dec 1;4(4):195-196. doi: 10.1111/j.1708-8305.1997.tb00821.x.
In France, as in most industrialized countries, the seroprevalence of hepatitis A virus (HAV) infection decreases due to improvements in hygiene and sanitation, but is still frequent in developing countries.1 In a cohort of military recruits followed up in France, this rate fell from 50% in 1978 to 16% in 1994.2 It is likely, therefore, that young travelers from industrialized countries would not have prior immunity and would be more susceptible to HAV infection when visiting endemic areas.3 However, a safe and effective vaccine for hepatitis A has been available since 1992.4 To highlight the need for this vaccination in young people traveling to such countries, we report a cluster of cases of hepatitis A in a troop of French scouts after they visited a West African village.
在法国，如同大多数工业化国家一样，由于卫生和环境卫生条件的改善，甲型肝炎病毒（HAV）感染的血清流行率有所下降，但在发展中国家仍很常见。1在法国进行随访的一组新兵队列中，这一比率从1978年的50%降至1994年的16%。2因此，来自工业化国家的年轻旅行者很可能没有先前的免疫力，在访问流行地区时更容易感染HAV。3然而，自1992年以来已有一种安全有效的甲型肝炎疫苗。4为强调前往这些国家的年轻人接种这种疫苗的必要性，我们报告了一群法国童子军在访问一个西非村庄后发生的甲型肝炎病例群。
